US approves first medication for severe non-alcoholic fatty liver disease

NEW DELHI: The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease. The medication, Rezdiffra by Madrigal Pharmaceuticals, was found to improve liver scarring in a clinical trial with hundreds of patients suffering from non-alcoholic steatohepatitis (NASH), the most severe form … Read more

Elon Musk says first human patient has received Neuralink brain implant

In May, the company said it had received approval from the US Food and Drug Administration to conduct its first human trials. And late last year Neuralink said it was recruiting patients with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) for the trial. On X, Musk wrote that Neuralink’s first … Read more